 | This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (June 2023) |
Geoffrey von Maltzahn | |
|---|---|
 | |
| Nationality | American |
| Alma mater | Massachusetts Institute of Technology (S.B.) University of California, San Diego (M.S.) Massachusetts Institute of Technology (Ph.D.) |
| Awards | Lemelson-MIT Student Prize (2009) National Inventors Hall of Fame Collegiate Inventors Competition Graduate Prize (2009), Massachusetts Institute of Technology Randolph G Wei Award (2003) |
| Scientific career | |
| Fields | Bioengineering |
Geoffrey von Maltzahn is an American biological engineer and businessman in the biotechnology and life sciences industry who has founded a number of companies including Indigo Agriculture, Sana Biotechnology, Kaleido Biosciences, Seres Therapeutics, Axcella Health, Generate Biomedicines and Tessera Therapeutics.[1][2][3]
- ^ Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine Business Insider Retrieved 9 October 2017
- ^ "Former Juno execs unveil Sana, a new cell engineering biotech that's reportedly raising more than $800M". GeekWire. January 7, 2019.
- ^ "This Company Wants to Rewrite the Future of Genetic Disease". Wired. July 7, 2020.